New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
about
Evolutionary divergence and functions of the human interleukin (IL) gene familyShaping of monocyte and macrophage function by adenosine receptorsTransformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptorA large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genesThe macrophage: a therapeutic target in HIV-1 infectionInborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypesInterleukin-35: Expanding Its Job ProfileMendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunityTherapeutic strategies for the clinical blockade of IL-6/gp130 signalingInterleukin-23: as a drug target for autoimmune inflammatory diseasesNative cellulose nanofibrills induce immune tolerance in vitro by acting on dendritic cellsAnti-Inflammatory Effects of IL-27 in Zymosan-Induced Peritonitis: Inhibition of Neutrophil Recruitment Partially Explained by Impaired Mobilization from Bone Marrow and Reduced Chemokine LevelsSize-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitroInterleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implicationStat3 mediates myeloid cell-dependent tumor angiogenesis in miceIL-31-IL-31R interactions limit the magnitude of Th2 cytokine-dependent immunity and inflammation following intestinal helminth infectionIdentification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosisDivergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiotaInterleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.Hev b 6.01 and Hev b 5 induce pro-inflammatory cytokines and chemokines from peripheral blood mononuclear cells in latex allergy.Elevated expression of IL-12 and IL-23 in patients with primary immune thrombocytopenia.Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia.Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function.Timed action of IL-27 protects from immunopathology while preserving defense in influenzaIL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis.Trypanosomiasis-induced Th17-like immune responses in carp.Interleukin-35 induces regulatory B cells that suppress autoimmune disease.Th17 cells: effector T cells with inflammatory properties.A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo.Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticlesDendritic cell-based human immunodeficiency virus vaccine.Activation of JAK2-V617F by components of heterodimeric cytokine receptorsLipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophagesInterleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2ADesiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway.Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors.Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1.Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages.Ethanol regulates angiogenic cytokines during neural development: evidence from an in vitro model of mitogen-withdrawal-induced cerebral cortical neuroepithelial differentiation.Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro.
P2860
Q21245454-D3AE93E1-4C0E-4972-A579-FE39A7A12688Q24655330-A3FDDD03-1FE6-4DD6-B6AC-7FE57802F367Q24676526-87B9CFD7-3509-4026-8CE7-C1F487E80D88Q24680489-796C9551-62D1-42CF-AA57-F0ECC8D1B387Q26823236-B257A003-E3B5-4D1F-80CD-7557EEA3EC5AQ26825342-1570E522-6076-4CC4-B181-3434C77C442BQ26829619-43E4A493-57A0-4284-A8D8-B4FC26BC8DE8Q26862947-EA22BF38-66F9-4971-A75E-BA2EDA10BD35Q27002391-B6EF38E6-CFCF-4DD1-8CD0-A72D8864EB5CQ27009502-F1B8B023-CFBA-400C-B8CE-D998F07E302DQ27317032-BDABE48A-20CF-4465-AC45-8BB0C86C8417Q27318494-AA7F1806-CAA4-43FE-892F-221C449D8FA8Q27334432-F49F86BF-671C-4511-BB26-BF15911F5243Q28265856-FDE50070-15BE-403A-AE5C-9D0A9EE947E9Q28385532-A7738663-4DB3-45CE-B06D-F3B278D8440BQ28512078-B38EE6B5-0E36-4CF1-B037-7D62C79FECDBQ28533202-F7738FDF-90C3-4CC8-8D4B-B6FD6D9CEF44Q28731877-D624F352-F373-4F0D-A97C-0FDCC3BD8F1AQ30244926-4F005DAB-7A38-410C-90CA-8B138018D38EQ33268534-C965C69A-B3B5-4610-B2BC-ADC8C14D3EB0Q33416432-23A5F227-9C2F-48D1-AC8F-E60A27374A9BQ33420102-6F3425C9-60A7-46EE-AA77-051B55BAF084Q33566364-83D22D46-3ACD-4D06-983C-1DF2E1B11882Q33583784-1B419D50-C1F3-49A5-99E5-764A2CD7794AQ33651440-AA3CBEAF-7FEF-4EFC-BFBC-8DBCDDCC7966Q33707467-506D3F92-CC26-40A7-B6BA-79119DC2DE07Q33721777-40A0AB86-C980-40C7-9700-1DA0CE813404Q33732092-466DA0EF-AC96-4902-9111-2E551619F7A7Q33812525-65A5836E-F318-476C-9E27-45802D56CDD5Q33825688-F5298309-C510-4D8D-A9BA-DB3D2AFBE2C3Q33874652-3D0A091D-F59A-4029-8FBE-FE6AED9A23FEQ33883366-9098ECB4-0C07-4EE1-B4E3-4FE769672D83Q33919041-BE97782D-BECB-4042-A0F9-C60862034896Q33929587-5EC7565A-FC3F-495B-9042-E08F147ABF76Q33938235-57B17E43-CE74-4F45-A378-ADBF6E8C0BCEQ33959754-1B293CF1-1F4D-4522-BE2E-21B0E286AEBCQ33967201-D22D7996-9028-4946-B5A7-37A92A7CA7BAQ33972053-2385388D-356E-4B1E-9CDF-4F5EA952B819Q34016262-DC3245AA-DE64-487D-A23C-F8F41EE91A28Q34066925-F895F119-BEC9-44A6-9CBB-003297FE6C6F
P2860
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
@ast
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
@en
type
label
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
@ast
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
@en
prefLabel
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
@ast
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
@en
P2860
P356
P1476
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
@en
P2093
Christopher A Hunter
P2860
P304
P356
10.1038/NRI1648
P577
2005-07-01T00:00:00Z